School-Based Treatment With ACT to Reduce Transmission

PHASE4CompletedINTERVENTIONAL
Enrollment

10,746

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Malaria
Interventions
DRUG

Dihydroartemisinin-piperaquine (DP)

Intermittent preventive treatment (IPT) with dihyroartemisinin-piperaquine (DP) will be delivered to participating students monthly, for up to 6 rounds of treatment during one school year. DP will be given once a day for 3 days, using full strength tablets (40/320mg) according to weight-based guidelines. Treatment will be directly observed, and will not be blinded.

Trial Locations (1)

PO Box 7475

Infectious Diseases Research Collaboration, Kampala

All Listed Sponsors
collaborator

Infectious Diseases Research Collaboration, Uganda

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of Durham

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT02009215 - School-Based Treatment With ACT to Reduce Transmission | Biotech Hunter | Biotech Hunter